Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • qnc
    Member
    • Jun 2010
    • 51

    #1

    Hello from I.O.O Gentics

    Hi everyone,

    We are just starting to look at next gen sequencing for mutation detection and have a lot of questions so I hope to get the current answers and thoughts on here.

    Traditionally we use 50k Chips to find a linked region in a family affected with Retinitis Pigmentosa. Then we would simply Sanger sequence the genes in that region to find mutations.

    We are hoping that Next Gen will be faster and more efficient and cheaper.

    The first problem we have encountered is repeat masking. We hoped to use Agilent eArray to design 75bp pair end long baits to read across our region and then use one of the platforms SOLiD or Illumina to sequence across the region.

    We hoped to then use the alignments of the affected vs the unaffected to find putative mutations which would then be tested for segregation and finally against a panel of normals.



    however some of our regions are rich in Repeats and the Repeat Maskers are stopping baits designs in that region.

    I will post this and many other questions elsewhere in the forum but if someone could recommend a strategy we would be very grateful.

    Thanks and its great to be part of this forum

Latest Articles

Collapse

  • SEQadmin2
    16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
    by SEQadmin2




    NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...
    Today, 06:46 AM
  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-28-2026, 09:57 AM
0 responses
24 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-28-2026, 09:51 AM
0 responses
15 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
71 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
48 views
0 reactions
Last Post SEQadmin2  
Working...